欢迎来到 BioAuxilium中国区代理商/公司/官网
全国咨询热线: 18372041646
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:18771149750

传真:15172469628

邮箱:sales@amyjet.com

新闻中心
logo.jpg

<

艾美捷科技代理Helvetica Health Care品牌全系列产品


Helvetica Health Care是一家位于瑞士日内瓦的医疗保健公司,致力于通过创新的产品和技术来管理健康和提高生活质量。作为瑞士生物技术协会的成员,Helvetica Health Care通过了ISO 13485认证,在质量和创新方面坚持最高标准。涵盖各种质量控制和验证面板,适用于不同的分子测试平台和检测。这些产品有多种规格,可用于单一或多种分析物的检测,帮助实验室监控测试性能,确保测试的准确性和可靠性。其质量控制和验证组合可根据产品配置、填充量和分析物浓度进行定制,满足不同平台的需求。


▎Helvetica Health Care产品线

Helvetica Health Care公司的产品涵盖:抗体、生命科学产品、血液分离产品、临床/诊断样本、质控品与标准品、分子生物学产品、细胞因子与生长因子、ELISA试剂盒/Western印迹相关产品、微生物、氧化应激产品、诊断产品以及人血浆制品。


HelveticaHealthCare页面.png


▎Helvetica Health Care部分产品列表


货号产品描述
NATFRC-6CNATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL)
NATCV9-6CNATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL)
NATRPC2.1-BIONATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL)
NATRVP2.1-BIONATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA)
NATRVP2.1-BIO PlusNATtrol Respiratory Verification Panel 2 Plus (+NATCOV(MR)-BIO) (24x 0.6 ml + 1x 0.6 ml)
NATRVP2-QIANATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA)
NATSARS(COV2)-VPNATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL)
NATSARS(COV2)-ERCSARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL)
NATSARS(COV2)-ERC1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Positive Control (6x 1.0 ml)
NATSARS(COV2)-NEGSARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL)
NATSARS(COV2)-NEG1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Negative Control (6x 1.0 ml)
NATSARS(COV2)-STSARS-Related Coronavirus 2 (SARS-CoV-2) Stock
NATSARS(COV2-SA)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL)
NATSARS(COV2-UK)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL)
0810229-0.5mgCoronavirus 229E Lysate (0.5 mg)
0810587SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg)
0810587-0.5mgSARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg)
0810587CFHI-0.5mLSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL)
0810587CFHISARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL)
0810587UVSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL)
0810589CFHISARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL)
0810589UVSARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL)
0810590CFHISARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810590UVSARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL)
0810617UVSARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) Culture Fluid (UV))
0810618UVSARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) Culture Fluid (UV)
0810619UVSARS-CoV-2 Iso1 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810620UVSARS-CoV-2 Iso2 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810621UVSARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) CF (UV Inactivated)
0810622UVSARS-CoV-2 Lineage B.1.595_2020 (NY-Wadsworth-33126-01/2020) CF (UV Inactivated)
0810612CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810612UVSARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL)
0810613CFHISARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL)
0810613UVSARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL)
0810614CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810614UVSARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL)
0810616CFHISARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL)
0810616UVSARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL)
0810617CFHISARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) – CFHI (1.0 ml)
0810618CFHISARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) – CFHI (1.0 ml)
0810619CFHISARS-CoV-2 Lso1 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810620CFHISARS-CoV-2 Lso2 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810621CFHISARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) – CFHI (1.0 ml)
0810622CFHISARS-CoV-2 Lineage E3.1.595J2020 (NYWadsworth-33126-01/2020) – CFHI (1.0 ml)
0810623UVSARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated)
0810623CFHISARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated)
0810624UVSARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated)
0810624CFHISARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated)
0820010CFHIVeroE6 Culture Fluid (Heat Inactivated) (1 mL)
0801043Goat Anti-SARS-CoV-2 Polyclonal Serum (0.5 ml)
0831042SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL)
0831043SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x1.0mL)
NATSARS-STCoronavirus SARS Stock (Qualitative) (1 mL)
NATCOV(229E)-STCoronavirus 229E Stock (Qualitative) (1 mL)
0810229CFHICoronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL)
0810229Coronavirus Strain: 229E Lysate
0810229UVCoronavirus (Strain: 229E) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(NL63)-STCoronavirus NL63 Stock (Qualitative) (1 mL)
0810228CFHICoronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL)
0810228Coronavirus Strain: NL63 Lysate
0810228UVCoronavirus (Strain: NL63) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(OC43)-STCoronavirus OC43 Stock (Qualitative) (1 mL)
0810024CFHICoronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL)
0810024Coronavirus Strain: OC43 Lysate
NATMERS-STMERS-CoV Stock (Qualitative) (1 mL)
NATMR-BIONATtrol MERS Recombinant Pack (2x 0.2 ml +0.5 ml)
NATCOV(MR)-BIONATtrol MERS-S. Cerevisiae (0.6 ml)
0810575MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(1mg)
0810575-0.5mgMERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(0.5mg)
CV033122COVID-19 Cross Over Panel (40x 1.0 ml)




" data-original="http://bioauxilium.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Helvetica Health Care品牌全系列产品">
艾美捷科技代理Helvetica Health Care品牌全系列产品
...
阅读详情
invivoCrown IV0119替换BioXCell BE0004-1 invivoCrown IV0119替换BioXCell BE0004-1
InVivoPro Anti-Mouse CD8α in vivo antibody, Clone 53-6.7 ...
阅读详情
invivoCrown IV0115替换BioXCell BE0060 invivoCrown IV0115替换BioXCell BE0060
InVivoPro Anti-Mouse VEGFR2(CD309) in vivo antibody, Clone DC101 ...
阅读详情
invivoCrown IV0116替换BioXCell BE0016-2 invivoCrown IV0116替换BioXCell BE0016-2
InVivoPro Anti-Mouse CD40 in vivo antibody, Clone FGK45 ...
阅读详情
invivoCrown IV0103替换BioXCell BE0075-1 invivoCrown IV0103替换BioXCell BE0075-1
InVivoPro Anti-Mouse Ly6G in vivo antibody, Clone 1A8 ...
阅读详情
invivoCrown IV0114替换BioXCell BE0213 invivoCrown IV0114替换BioXCell BE0213
InVivoPro Anti-Mouse CSF1R (CD115) in vivo antibody, Clone AFS98 ...
阅读详情
invivoCrown IV0117替换BioXCell BE0223 invivoCrown IV0117替换BioXCell BE0223
InVivoPro Anti-Mouse CD8β (Lyt 3.2) in vivo antibody, Clone 53-5.8 ...
阅读详情
exocell.jpgemfret.jpg

艾美捷科技代理Emfret品牌。

Emfret是一家专注于免疫学和血液学研究的生物技术公司,以其高质量的抗体和试剂而闻名,特别是在血小板和免疫细胞研究领域。


   Emfret公司的产品与服务

● 抗体

血小板抗体:用于检测和研究血小板表面标记和功能。

免疫细胞抗体:用于T细胞、B细胞、单核细胞等免疫细胞的研究。


● 试剂盒

血小板功能检测试剂盒:用于评估血小板活化和聚集。

免疫细胞分型试剂盒:用于多参数流式细胞术分析。


● 定制服务:

抗体开发:根据客户需求开发定制抗体。

试剂盒定制:根据客户需求设计定制试剂盒。


   Emfret产品应用领域

● 血液学研究,用于血小板功能和血液疾病研究。

● 免疫学研究,用于免疫细胞表型和功能研究。

● 癌症研究,用于肿瘤免疫微环境和循环肿瘤细胞研究。

● 传染病研究,用于病原体特异性免疫反应研究。

● 临床诊断,支持血液和免疫相关疾病的诊断和监测。

<
   产品列表
Cat.No.AntigenCloneIsotypeFormApplicationsSize
C301Antibodies for Mouse Platelet Depletionpolyclonal non-immune rat immunoglobulinsRat IgGpurif.negative control for #R3000.5 mg
D200Two-Color Analysis of Mouse Platelet ActivationWug.E9 JON/ARat IgG2b/IgG1FITC PEflow cytometry2 x 1.0 ml; 200 tests
M011-0GPVIJAQ1Rat IgG2apurif.IP, IHC, WB0.1 mg
M011-1GPVIJAQ1Rat IgG2aFITCFC, IHC1.5 ml; 300 tests
M021-0Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61)Leo.H4Rat IgG2bpurif.IP, IHC, block0.5 mg
M021-1Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61)Leo.H4Rat IgG2bFITCFC, IHC1.5 ml; 300 tests
M022-0Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61)Leo.A1Rat IgG1purif.IP, IHC0.5 mg
M023-2Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61)JON/ARat IgG2bPEFC (activ. form)1.5 ml; 300 tests
M024-0Integrin alphaIIb (GPIIb, CD41)MwReg30Rat IgG1purif.IP, IHC, generation of Fab fragments6 mg
M025-0Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61)Leo.F2Rat IgG2apurif.IP, IHC0.5 mg
M025-1Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61)Leo.F2Rat IgG2aFITCFC, IHC1.5 ml; 300 tests
M025-2Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61)Leo.F2Rat IgG2aPEFC, IHC1.5 ml; 300 tests
M025-3Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61)Leo.F2Rat IgG2aDyLight 649FC, IHC1.5 ml; 300 tests
M030-0Integrin beta3 chain (GPIIIa, CD61)Luc.A5Rat IgG2apurif.IP, IHC, WB0.5 mg
M031-0Integrin beta3 chain (GPIIIa, CD61)Luc.H11Rat IgG2bpurif.IP, IHC, WB0.5 mg
M031-1Integrin beta3 chain (GPIIIa, CD61)Luc.H11Rat IgG2bFITCFC, IHC1.5 ml; 300 tests
M040-0GPIbalpha (CD42b)Xia.G5Rat IgG2bpurif.IP, IHC0.5 mg
M040-1GPIbalpha (CD42b)Xia.G5Rat IgG2bFITCFC, IHC1.5 ml; 300 tests
M040-2GPIbalpha (CD42b)Xia.G5Rat IgG2bPEFC, IHC1.5 ml; 300 tests
M040-3GPIbalpha (CD42b)Xia.G5Rat IgG2bDyLight 649FC, IHC1.5 ml; 300 tests
M041-0GPIbalpha (CD42b)Xia.H10Rat IgG2apurif.FC, IHC0.5 mg
M041-1GPIbalpha (CD42b)Xia.H10Rat IgG2aFITCFC, IHC1.5 ml; 300 tests
M042-0GPIbalpha (CD42b)Xia.G7Rat IgG1purif.IP, IHC, WB0.5 mg
M042-1GPIbalpha (CD42b)Xia.G7Rat IgG1FITCFC, IHC1.5 ml; 300 tests
M043-0GPIbalpha (CD42b)Xia.B2Rat IgG2apurif.IP, IHC, block0.5 mg
M043-1GPIbalpha (CD42b)Xia.B2Rat IgG2aFITCFC, IHC1.5 ml; 300 tests
M050-0GPIbbeta (CD42c)Xia.C3Rat IgG2apurif.IP, IHC, WB0.5 mg
M050-1GPIbbeta (CD42c)Xia.C3Rat IgG2aFITCFC, IHC1.5 ml; 300 tests
M051-0GPIX (CD42a)Xia.B4Rat IgG1purif.IP, IHC0.5 mg
M051-1GPIX (CD42a)Xia.B4Rat IgG1FITCFC, IHC1.5 ml; 300 tests
M060-1GPV (CD42d)Gon.C2Rat IgG1FITCFC, IHC1.5 ml; 300 tests
M061-0GPV (CD42d)Gon.G6Rat IgG2apurif.IP, IHC0.5 mg
M061-1GPV (CD42d)Gon.G6Rat IgG2aFITCFC, IHC1.5 ml; 300 tests
M070-0Integrin alpha2 chain (CD49b, GPIa)Sam.G4Rat IgG2bpurif.IP, IHC, block0.5 mg
M070-1Integrin alpha2 chain (CD49b, GPIa)Sam.G4Rat IgG2bFITCFC, IHC1.5 ml; 300 tests
M071-0Integrin alpha2 chain (CD49b, GPIa)Sam.C1Rat IgG2bpurif.IP, IHC0.5 mg
M071-1Integrin alpha2 chain (CD49b, GPIa)Sam.C1Rat IgG2bFITCFC, IHC1.5 ml; 300 tests
M080-0Integrin alpha5 chain (CD49e)Tap.A12Rat IgG1purif.IP, IHC0.5 mg
M080-1Integrin alpha5 chain (CD49e)Tap.A12Rat IgG1FITCFC, IHC1.5 ml; 300 tests
M110-0CD9Nyn.H3Rat IgG2apurif.IP, IHC, WB0.5 mg
M110-1CD9Nyn.H3Rat IgG2aFITCFC, IHC1.5 ml; 300 tests
M120-0CD31 (PECAM-1)Pec.H3Rat IgG1purif.IP, IHC, WB0.5 mg
M130-0CD62P (P-selectin)Wug.E9Rat IgG1purif.IP, IHC0.5 mg
M130-1CD62P (P-selectin)Wug.E9Rat IgG1FITCFC, IHC1.5 ml; 300 tests
M130-2CD62P (P-selectin)Wug.E9Rat IgG1PEFC, IHC1.5 ml; 300 tests
P140-1fibrinogenpolyclonalRabbit IgGFITCFC, IHC1.5 ml; 300 tests
P150-1von Willebrand Factor (vWF)polyclonalRabbit IgGFITCFC, IHC1.5 ml; 300 tests
P180-1negative controlpolyclonalRabbit IgGFITCFC, IHC1.0 ml; 200 tests
P190-1negative controlpolyclonalRat IgGFITCFC, IHC1.0 ml; 200 tests
P190-2negative controlpolyclonalRat IgGPEFC, IHC1.0 ml; 200 tests
P190-3negative controlpolyclonalRat IgGDyLight 649FC, IHC1.0 ml; 200 tests
R300Antibodies for Mouse Platelet Depletionpolyclonal anti-GPIb alphaRat IgGpurif.platelet depletion0.5 mg
X488Antibodies for In Vivo Mouse Platelet Labelinganti - GPIbbeta derivativeRat IgGDyLight 488in vivo100 µg
X649Antibodies for In Vivo Mouse Platelet Labelinganti - GPIbbeta derivativeRat IgGDyLight 649in vivo100 µg


<<< " data-original="http://bioauxilium.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Emfret品牌">
艾美捷科技代理Emfret品牌
...
阅读详情
invivoCrown IV0120替换BioXCell BE0015-1 invivoCrown IV0120替换BioXCell BE0015-1
InVivoPro Anti-Mouse CD28 in vivo antibody, Clone 37.51 ...
阅读详情

Copyright © 2026 Powered by BioAuxilium中国区代理商/公司/官网   鄂ICP备10204150号-10 sitemap